Drugs that target specific tumors are harbingers of a new era of genetically informed medicine.
Advertisement
The Scientist
Most Recent
Institut Curie researchers Bruno Goud, a biologist, and Patricia Bassereau, a physicist, talk about their fruitful, decade-long collaboration exploring the physics of membrane trafficking in a Skype interview conducted by Associate Editor Richard P. Grant.
Recent clinical trials have reignited the interest in simple anti-inflammatory drugs like aspirin for controlling the inflammation associated with cancer. The results suggest that these drugs reduced the risk of relapse as well as cancer formation ac
Can tumors—which can originate from, and often resemble, chronically inflamed tissue—be curtailed using familiar anti-inflammatory agents, without their side effects?
The Great Sperm Whale, Noble Cows & Hybrid Zebras, Radioactive, Science-Mart
Preston Estep discusses the role that telomeres play in the aging process.
A snapshot of the highest-ranked articles from a 30-day period on Faculty of 1000
Epigenetic marks laid down during the cold months of the year allow flowering in spring and summer.
The study of how covalent marks on DNA and histones are involved in the origin and spread of cancer cells is also leading to new therapeutic strategies.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
